Dr. Manoj Nargund is a medical doctor & post-graduate (MD) in Pharmacology from University of Mumbai, India, with thesis on â€œAnti-oxidant Effect of Vit E in HTâ€. He also holds a Diploma in Pharmaceutical Business Management. He has earlier served as Resident Medical Officer in ICCU/Internal Medicine in prestigious public hospitals at Mumbai for 3 years, & has been on teaching faculty for Pharmacology for medical & pharmacy graduates, & has 5 publications in peer-reviewed journals. As an Asia Pacific Medical Affairs & Clinical R&D professional in pharmaceutical industry for last 21 years, he has introduced & developed key Cardiology products in hypertension, dyslipidemia, coronary heart disease, thrombosis, arrhythmia, & heart failure. Some of his key achievements include - leading Cardiology advisory boards including for Lp-PLA2 inhibitor; introducing angiotensin receptor blockers (ARBs), hypolipidemics, anti-anginals, anti-thrombotics & thrombolytics. He is passionate about learning & implementing preventive strategies for Atherosclerotic Cardiovascular Disease (ASCVD).
Dr. Samer Ellahham has served, in the past, as Chief Quality Officer for SKMC from 2009-2018.Dr. Ellahham is a recognized innovative leader in quality, safety, patient experience, risk management and the use of robust performance improvement in improving healthcare delivery. He is a Certified Professional in Healthcare Quality (CPHQ) by The National Association for Healthcare Quality (NAHQ)
SAMER ELLAHHAM(Research Area)
Cardiology, Clinical research, Risk Management, Public Health
Dr. Ghanem was qualified in 1968, Mansoura University, Egypt. He gained all postgraduate
experience in the UK where he was promoted in posts up to the consultant level. He practiced as consultant Urologist in the UK, Saudi Arabia, and Egypt. During his career life, he reported over 60 articles of which he made important discoveries in medicine, physiology, urology, nephrology, cardiovascular and surgery. He is now the Editor-in-Chief for The Surgical Medicine Open Access Journal (SMOAJ).
AHMED N. GHANEM(Research Area)
He discovered two new types of vascular shocks, proved that one physiological law is wrong and provided an alternative. He resolved the puzzles of 3 clinical syndromes; the transurethral of the prostate (TURP) syndrome, the loin pain haematuria syndrome (LPHS) and adult respiratory distress syndrome (ARDS).
Ljudmila Stojanovich received her Ph.D. in Medicine, with the thesis â€œNeuropsychiatric manifestations in patients with Systemic Lupus Erythematosusâ€ in 1999. She is the scientific director in the Bezhanijska Kosa, University Medical Center of Belgrade University, where she is currently a Full Research Professor. Dr. Stojanovichâ€™s research focuses on Systemic Lupus Erythematosus, Antiphospholipid Syndrome, and Vaccination in patients with Autoimmune Rheumatic diseases. She is an author of three monographs and of about 250 articles on various aspects of Autoimmune Rheumatic disorders, published in international and domestic journals and in conference proceedings. She is in Editorial Boards (Editorial Boards LUPUS (LONDON). /Reviewer in the â€œCURRENT CONTENSTSâ€ or â€œScience citation indexâ€, like LUPUS REWIEWER DATABAS, Cellular and Molecular Neurobiology, The Journal of Vaccine
LJUDMILA STOJANOVICH(Research Area)
â€¢SYSTEMIC LUPUS ERYTHEMATOSUS
â€¢NEUROPSYCHIATRIC MANIFESTATIONS IN PATIENTS WITH
AUTOIMMUNE RHEUMATIC DISEASE
â€¢VACCINATION IN PATIENTS WITH AUTO-IMMUNE INFLAMMATORY
Dr. Abouelmagd has been a cardiologist for many years; he is currently working as a registrar of cardiovascular medicine at Mouwasat Hospital, Riyadh, KSA. He received his MBBCh degree and ranked the 2nd in his class with â€œExcellent with an honorary degreeâ€ in 2010. He finished his residency in cardiovascular medicine and received his M.Sc degree at faculty of medicine, Al Azhar University, Cairo, Egypt
He is in the pathway of Membership of the Royal Colleges of Physicians of the United Kingdom and ongoing to be an associate lecturer of cardiovascular medicine at faculty of medicine, Al Azhar University, Cairo, Egypt.
KHALED ABOUELMAGD(Research Area)
Dr. Abouelmagd subspecialty interests include non-invasive cardiology, cardiac imaging especially Echocardiography as he is board certified from European Association of Cardiovascular Imaging (EACVI) in Adult Transthoracic Echocardiography and board certified from National Board of Echocardiography (USA), Examination of Special Competence in Adult Echocardiography (ASCeXAM). You can reach him at Abouelmagd.email@example.com
I am Dr. Mojtaba Mafi M.D., Medical Doctor/ Physician, graduated from Tehran University, School of
Medicine with honor. I studied in neurosurgery ward and graduated with A score with a thesis on
Meningioma Brain Tumor for 6 years.
With continuing my practice with special consideration on psychosomatic disorders, I completed
many postgraduate courses on health psychology, addiction medicine, sexual disorders therapy
successfully. I passed many postgraduate courses in Neuro, approved by Medical sciences
university. As well, I have been passed postgraduate courses on Nutrition, Gastroenterology and
Hepatology, Obesity treatment and diabetes approved by Tehran University of Medical Sciences.
I successfully passed more than 10 programs with certificates and membership in the Iranian Association of Gastroenterology and Hepatology
MOJTABA MAFI(Research Area)
I am working clinically on patients with Brain Tumor and publishing my results on these topics:
1. Recurrent Meningioma
2. Trigeminal neuralgia
3. Radiation induced meningioma
4. Behavioral change in Brain Tumors
5. DVT prevalence and management among patients with meningioma
and some others.
Pierre Deharo has done his Master of Science at Marseilles University, Director Pr MC ALESSI (Inserm UMR 1062) Impact of thienopyridines on platelet CD40L biodisponibility after an Acute Coronary Syndrome in relation with bleeding events.
Medical thesis: Out of hospital cardiac arrest and coronary angiography, experience from our center.
PIERRE DEHARO(Research Area)
Pierre Deharo interest includes Adenosine expression, adenosine receptors, and coronary artery disease.